Eric J. Nestler, MD, PhD, Assumes Role as President of the Society for Neuroscience During 2016 Annual Meeting
Eric J. Nestler, MD, PhD, Dean for Academic and Scientific Affairs, Director of the Friedman Brain Institute (FBI) and Nash Family Professor of Neuroscience at the Icahn School of Medicine at Mount Sinai, began his term as President of the Society for Neuroscience (SFN) at the 2016 annual meeting last evening. Founded in 1969, The Society for Neuroscience is the world’s largest organization of brain and nervous system scientists and physicians, with nearly 40,000 members from more than 90 countries.
During his one-year term as president between 2016 and 2017, Dr. Nestler will guide the venerable society to support the neurosciences in a myriad of ways. Some of the themes he plans to address during his tenure include promoting a diverse workplace in the neuroscience field, working with academic institutions and government agencies to reduce the administrative burden on the neuroscience research enterprise, and promoting optimal translation of basic discoveries into clinical advances, while recognizing the crucial importance of a strong investment in basic research.
Dr. Nestler was named president-elect in July 2015. The long delay between election as president-elect and assumption of presidential duties ensures continuity, allowing incoming presidents to carefully observe two predecessors at work before taking the position.
Dr. Nestler’s research focuses on the neurobiological basis of drug addiction and depression. His laboratory, funded by the National Institute on Drug Abuse, National Institute of Mental Health, and the Hope for Depression Research Foundation, has pioneered studies to understand, at the molecular level, how stress and drug abuse change nerve cells and their brain circuits to cause behavioral abnormalities and to use this knowledge to develop improved treatments.
“Since he assumed his leadership role at Mount Sinai in 2008, Eric has overseen transformational growth of the neuroscience community under the auspices of The Friedman Brain Institute,” says Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System. “We are proud and so pleased that our friend and colleague will be leading the society forward. I have no doubt that his vision for and commitment to a better understanding of the nervous system will benefit the SFN, as it has for the neurosciences here at Mount Sinai.”
Uniquely, FBI integrates all neuroscience efforts throughout Mount Sinai, from basic research in animal and cell models in the Icahn School of Medicine to the delivery of clinical care across the Mount Sinai Health System. Under Dr. Nestler’s leadership, the neuroscience program has seen unprecedented growth. In the past 10 years, more than 35 basic neuroscience faculty members have been recruited to Mount Sinai, with clinical research and treatment programs experiencing similar expansion. The FBI’s research and clinical faculty members are national and international leaders, committed to an improved understanding of the nervous system and to real clinical advances in diagnosis and treatment across a broad range of brain and spinal cord disorders. The Fishberg Department of Neuroscience at Mount Sinai is ranked No.3 in the nation for funding from the National Institutes of Health.
To learn more about the Friedman Brain Institute, please visit: http://icahn.mssm.edu/research/friedman
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.